Active Stocks in Focus: Horizon Pharma PLC (NASDAQ:HZNP), Denbury Resources Inc. (NYSE:DNR) 

Active Stocks

Shares of Horizon Pharma PLC (NASDAQ:HZNP), declined – 6.64% to $16.81, amid its last exchanging session.


Horizon Pharma plc, once in the past Vidara Therapeutics International Public Limited Company, is a forte biopharmaceutical organization concentrated on distinguishing, creating, getting or in-permitting and commercializing separated items that address unmet medicinal needs. The Company showcases an arrangement of items in joint pain, irritation and vagrant maladies.

Horizon Pharma announced that Glass Lewis & Co. (“Glass Lewis”), one of the country’s driving intermediary admonitory administrations, issued a report supporting Horizon Pharma’s endeavors to assemble for two related extraordinary conferences of Depomed, Inc. (“Depomed”) shareholders — one to uproot the present’s majority Depomed chiefs and cancelation a progression of late revisions to Depomed’s standing rules (the “Evacuation and Bylaw Amendments Special Meeting”) and a second to choose substitution executives (the “Race Special Meeting”).

Glass Lewis prescribed that Depomed shareholders PROVIDE CONSENT FOR Horizon Pharma’s sales for the extraordinary’s submitting so as to assemble conferences their WHITE and BLUE intermediary cards to Horizon Pharma’s intermediary specialist, MacKenzie Partners, Inc. Glass Lewis is the second intermediary counseling support of make that suggestion. On September 28, 2015, Horizon Pharma announced that Institutional Shareholder Services (“ISS”) had prescribed that Depomed shareholders ought to give such assent.

Shares of Denbury Resources Inc. (NYSE:DNR), slanted 2.85% to $2.53, amid its last exchanging session.

Denbury Resources Inc. is an autonomous oil and regular gas organization. The Company’s operations are engaged in two working ranges: the Gulf Coast and Rocky Mountain districts.

Denbury Resources proclaimed that its Board of Directors has chosen to suspend the Company’s present $0.0625 per share quarterly money profit, beginning with the final quarter of 2015. The Company will pay its some time ago pronounced second from last quarter money profit on September 29, 2015.

By suspending the profit, the Company will free up about $22 million of money every quarter, or $88 million yearly, which can be coordinated to different uses numbering, in addition to other things, obligation decrease, changes in capital spending, or repurchases of shares of the Company’s basic stock. Independently, the Company’s Board of Directors has reestablished the capacity for the Company to repurchase offers under its once in the past approved offer repurchase program which was suspended in November of 2014. Under that program about $222 million stays approved, with no set lapse date and no necessity that the approved sum be utilized as a part of entire or to some degree.

Notes to the Stakeholders:

This article is the intellectual property of The purpose of penning down this article has been just to share information. Moreover, it is firmly believed that all the information that are revealed in this article are from reliable sources, however, we do not make any representations or warranties whatsoever of any kind, express or implied, as far as the completeness, accurateness, or reliability with respect to this article is concerned.

All the respectable visitors to this website are kindly advised to conduct their own independent research into individual stocks prior to making a purchase decision.

This article contains an advanced information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as well as statements regarding the forseeable frequent growth of the market for the corporation’s products, the corporation’s capability to fund its capital requirement in the close-to term and in the long term; pricing pressures; etc.

Furthermore, any statement that expresses or involves discussions with respect to forecast, expectations, beliefs, strategy, projection, objectives, aims, assumption, or future events or performance may be forward looking statements. In addition, the forward-looking statements are wholly and solely based upon expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. An easy way to identify the forward looking statements is through the use of such words as be expecting, will, foresee, guess, considered, or by statements that indicates certain actions may, could, should/might occur.


About the Author

Kristen Rose
University graduate with a bachelor's degree in business administration. Kristen is the Finance Editor, overseeing markets, economics, wealth, fintech, banking, and regulation coverage, based in London. She like to keep things simple, enjoy life, & appreciate everything around me.♡